The transcription repressor Bcl-6 is necessary for the development of various types of cells of the immune system, including germinal center B cells and CD4 + follicular helper T cells (T FH cells) [1] [2] [3] . Bcl-6 has also been linked to promoting the formation of memory cells from both CD4 + T cells and CD8 + T cells [4] [5] [6] [7] [8] . In the development of both T FH cells and memory cells, an important role for Bcl-6 is to inhibit the expression of Blimp-1, a transcription regulator required for the terminal differentiation of effector cell populations 2, 6, 9, 10 . Although this is one critical activity for Bcl-6 in several populations of cells of the immune system, it has remained unclear which additional gene pathways are regulated by Bcl-6 to promote the functional characteristics of different T cell populations 11 .
An important functional difference between effector cell populations and memory cell populations is their metabolic states [12] [13] [14] . Studies of CD8 + T cells have shown that genes encoding molecules in the glycolysis pathway are induced in effector cells, which results in a switch to aerobic glycolysis for energy production [15] [16] [17] . This is thought to be essential for the rapid proliferative burst of activated T cells and for the promotion of aspects of effector cell functions 15, 18 . In contrast, the glycolysis pathway is downregulated in CD8 + memory T cells 19 , which causes the cells to use mitochondrial fatty acid oxidation as a predominant form of cellular metabolism, resulting in a shift to a catabolic state 16, 20 . Notably, experimental inhibition of glycolysis promotes the formation of memory CD8 + T cells, while artificial activation of the glycolysis pathway causes the cells to 'preferentially' adopt an effector state 14, 21 . Such observations suggest that the use of different metabolic pathways in T cells actively contributes to differentiation outcomes.
The transcription-regulatory events that induce genes encoding glycolytic molecules for the promotion of effector cell differentiation have been elucidated 13, 19 . Signaling via the T cell antigen receptor and costimulation via the coreceptor CD28 activate the transcription factor c-Myc, which is required for initial upregulation of the expression of glucose transporters and rate-limiting glycolysis enzymes 15 . Additionally, signaling via interleukin 2 (IL-2) promotes the sustained expression of genes encoding glycolytic molecules in effector CD8 + T cells, with the hypoxia factor HIF-1α being required for this activity 17 . In contrast to the expanding knowledge of the events that induce the glycolysis pathway in effector T cells, little information is available about the transcription-regulatory events that downregulate or, alternatively, prevent the expression of these genes to enhance the formation of memory cells.
Research has indicated that the gene-expression programs of T FH cells and memory T cells have several common features, which suggests a close relationship between these two populations 22 . One similarity between T FH cells and memory T cells is the role of Bcl-6 in determining aspects of each gene program 4, 23 . It appears that the abundance of Bcl-6 is partially responsible for defining the unique characteristics for the two gene programs, with the largest amounts of Bcl-6 promoting T FH differentiation and moderate Bcl-6 expression being needed for memory cell development 5, 7, 24 . One environmental signal that regulates Bcl-6 expression in T cells is IL-2. Strong IL-2 signaling inhibits Bcl-6 expression, whereas low amounts of environmental IL-2 promote Bcl-6 expression 7, 9, [25] [26] [27] . Since IL-2 signaling also regulates the metabolic state of CD8 + T cells 17 , there is an inverse correlation between the ability of IL-2 signaling to functionally A r t i c l e s regulate Bcl-6 expression and the expression of genes encoding glycolytic molecules.
Here we discovered that Bcl-6 repressed the IL-2-sensitive expression of genes encoding glucose transporters and rate-limiting enzymes involved in glycolysis. By comparison of published microarray data sets, we observed an overlap in the identity of genes that were reciprocally regulated by HIF-1α versus Bcl-6, including numerous genes encoding molecules in the glycolysis pathway. The expression of the genes in this overlapping subset was also sensitive to IL-2 signaling. This led us to hypothesize that Bcl-6 might serve as a key repressor for the genes encoding molecules in the glycolytic pathway that are sensitive to IL-2 signaling and are expressed differently in effector and memory T cell states. We found that Bcl-6 directly repressed many genes encoding molecules in the glycolysis pathway and effectively functioned in direct opposition to the gene programs activated by HIF-1α and c-Myc. Additionally, the type 1 helper T cell (T H 1 cell) lineage-specifying transcription factor T-bet functionally inhibited the ability of Bcl-6 to repress genes encoding molecules involved in glycolysis. This suggests that the molecular balance of T-bet and Bcl-6 influences expression of the metabolic gene program.
RESULTS

Overlap of genes regulated by Bcl-6 and by HIF-1a
To start to address the question of which regulatory pathways Bcl-6 represses to promote the normal differentiation and activity of unique cells of the immune system, we used the web tool GEO2R to compare the gene-expression patterns of wild-type and Bcl-6-deficient bone marrow-derived myeloid cells from a published microarray study 28 . This analysis revealed that many genes encoding molecules involved in glycolysis, including rate-limiting enzymes and glucose transporters, were upregulated in Bcl-6-deficient cells ( Supplementary Table 1 ). These findings suggested a role for Bcl-6 in functionally repressing genes encoding components of the glycolysis pathway, at least in some circumstances.
There was a reciprocal expression pattern for Bcl-6 and HIF-1α in T cells responding to IL-2. Bcl-6 expression was inhibited in the presence of high concentrations of IL-2 (refs. 9,25,26) ( Figs. 1 and 2) , whereas HIF-1α expression is enhanced by IL-2 signaling 15, 17 . Therefore, we hypothesized that Bcl-6 might have a role opposing that of HIF-1α in the IL-2-sensitive regulation of target genes encoding glycolytic molecules. To begin to investigate this possibility, we compared the genes from the GEO2R analysis of Bcl-6 with genes identified as IL-2 sensitive and HIF-1α-dependent in a microarray study that analyzed wild-type and HIF-1α-deficient effector CD8 + T cells 17 . There was substantial overlap in the genes functionally activated by HIF-1α in CD8 + T cells and the genes functionally repressed by Bcl-6 in myeloid cells (Supplementary Table 1 ). The subset of genes regulated by both HIF-1α and Bcl-6 included genes encoding molecules of the glycolytic pathway, such as Slc2a3 and Slc2a1 (which encode the glucose transporters Glut3 and Glut1), and Hk2 and Aldoc ( Supplementary Table 1 ). It also included genes encoding important hydrolases that modify proteins (such as Plod2), as well as those encoding members of the EGL-9 family of hypoxia-inducible factors (such as Egln1) and prolyl 4-hydoxylases (such as P4ha1) ( Supplementary Table 1 ). This overlap suggested that Bcl-6 might functionally oppose the IL-2-sensitive, HIF-1αdependent gene program.
IL-2 regulates genes encoding glycolytic proteins
We next hypothesized that environmental IL-2 conditions might serve as a conserved stimulus in T H 1 cells and CD8 + type 1 cytotoxic T cells (T C 1 cells) that functionally regulates the expression of the overlapping subset of genes regulated by HIF-1α and Bcl-6. Consistent with published results obtained with CD8 + T cells 15, 17 , various genes in the glycolysis pathway were 'preferentially' expressed in CD8 + T C 1 cells in the presence of a high environmental concentration of IL-2 rather than a low environmental concentration of IL-2 ( Fig. 1 and  Supplementary Figs. 1 and 2a) . These included Slc2a3 and Slc2a1, as well as genes encoding enzymes important in the glycolytic pathway, including Aldoa, Aldoc, Pkm, Hk2 and Grhpr. Indeed, there was global induction of genes encoding the key components that regulate the glycolysis pathway and associated pathways in conditions of a high environmental concentration of IL-2, whereas their expression was much lower in conditions of a low concentration of IL-2 ( Fig. 1 and Supplementary Figs. 1 and 2a) . Several other genes in the overlapping subset of genes regulated by HIF-1α and Bcl-6 followed the same IL-2-sensitive gene-expression pattern as those encoding molecules in the glycolytic pathway in CD8 + T C 1 cells ( Fig. 1 and Supplementary  Fig. 2a ). Similar to the results obtained with CD8 + T C 1 cells, genes encoding molecules involved in the glycolytic pathway and associated pathways were 'preferentially' expressed in CD4 + T H 1 cells exposed to a high environmental concentration of IL-2 rather than in those exposed to a low environmental concentration of IL-2 ( Fig. 2 and Supplementary Figs. 2b and 3) . Notably, Bcl-6 expression inversely correlated with the expression of the glycolytic-pathway genes in both T H 1 cells and T C 1 cells, with Bcl-6 expression robustly induced in a low environmental IL-2 concentration 9,27 ( Figs. 1 and 2) . Bcl6 expression (relative) ** Figure 1 IL-2 signaling regulates the expression of genes encoding molecules in the glycolysis pathway in CD8 + T C 1 cells. Quantitative RT-PCR analysis of the abundance of transcripts from various genes (vertical axes) in primary CD8 + T cells cultured in T C 1-polarizing conditions (IL-12 and antibody to IL-4 (anti-IL-4)) and exposed to either a high environmental concentration of IL-2 (250 U/ml) (High IL-2) or a low environmental concentration of IL-2 (10 U/ml) (Low IL-2); results were normalized to those of the control gene Rps18 (which encodes ribosomal protein S18) and are presented relative to those obtained with a high concentration of IL-2, set as 1. *P < 0.01 and **P < 0.001 (unpaired Student's t-test). Data are representative of at least three or four independent experiments (error bars, s.e.m.).
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A r t i c l e s Bcl-6 regulates genes encoding glycolytic molecules The inverse correlation between the expression of Bcl-6 and that of genes encoding molecules involved in the glycolytic pathway in CD4 + T H 1 and CD8 + T C 1 cells led us to investigate whether Bcl-6 might be involved in the direct repression of this gene program. To start to test this hypothesis, we cloned promoter-reporter constructs for genes encoding molecules involved in the glycolytic pathway and additional genes from the overlapping subset of genes regulated by HIF-1α and Bcl-6. Notably, there was a reduction in the activity of the promoters of Slc2a3, Slc2a1 and Tpi1, as well as those of Plod2 and P4ha2, in response to Bcl-6 expression ( Fig. 3a and Supplementary Fig. 4a ). In control experiments, Bcl-6 expression alone did not repress the activity of the promoter-reporter vector or several other promoter-reporter constructs 29 ( Supplementary Fig. 4b ), which demonstrated that the vector itself did not contain any cryptic Bcl-6-binding sites. These data suggested that Bcl-6 was able to repress the promoter activity of a subset of genes encoding molecules involved in glycolysis and the IL-2-sensitive regulatory pathways controlled by HIF-1α. We next transfected a control or Bcl-6 expression vector into primary T H 1 cells that we differentiated in a high environmental concentration of IL-2 and analyzed the endogenous expression of genes encoding molecules in the glycolysis pathway. This experimental system assessed whether increasing Bcl-6 expression alone was sufficient to repress these genes in conditions in which HIF-1α and c-Myc would otherwise strongly promote their expression. Many genes encoding molecules in the glycolysis pathway, including Hk2 and Pkm, which encode rate-limiting enzymes, were repressed by the expression of Bcl-6 in primary T H 1 cells maintained in conditions of a high environmental concentration of IL-2 ( Fig. 3b and Supplementary Fig. 5 ). These data suggested that Bcl-6 expression dominantly repressed genes encoding molecules involved in the glycolysis pathway even when the cellular conditions were favorable for their expression.
If Bcl-6 participated in the direct repression of target genes encoding molecules in the glycolytic pathway in the context of T cells, then there would be an inverse correlation between the expression of those genes and the association of Bcl-6 with those loci. To examine this prediction, we used chromatin immunoprecipitation followed by Figure 2 Environmental IL-2 conditions regulate genes encoding molecules in the glycolysis pathway in CD4 + T H 1 cells. Quantitative RT-PCR analysis of the abundance of transcripts from various genes (vertical axes) in primary CD4 + T cells cultured in T H 1-polarizing conditions (IL-12 and anti-IL-4) in the presence of a low or high concentration of IL-2 (as in Fig. 1 ; results normalized and presented as in npg A r t i c l e s PCR (ChIP-PCR) to assess the association of Bcl-6 with the promoter regions of several genes encoding molecules in the glycolysis pathway in primary T H 1 cells exposed to a high or low environmental concentration of IL-2. In ChIP experiments, Bcl-6 associated with the promoters of Slc2a3, Slc2a1, Aldoc and Pkm in a low environmental concentration of IL-2, which coincided with the repression of these genes ( Fig. 3c and Supplementary Fig. 4c ). In contrast, in T H 1 cells exposed to a high environmental concentration of IL-2, the association of Bcl-6 with those promoters was diminished, which correlated with the upregulation of their expression ( Fig. 3c and Supplementary Fig. 4c ). We observed a similar inverse correlation for the binding of Bcl-6 and gene expression for Plod2 and P4ha2 ( Fig. 3c and Supplementary Fig. 4c ). Collectively, these data indicated that Bcl-6 associated with a subset of genes encoding molecules important to the glycolysis pathway in T H 1 cells and was functionally important for repressing their expression.
Bcl-6 binds to glycolytic molecule-encoding loci ChIP followed by high-throughput sequencing (ChIP-seq) has been used to examine the genomic localization of Bcl-6 in B cells and the T H 9 subset of helper T cells to define the mechanisms that Bcl-6 uses to repress target gene expression [30] [31] [32] [33] . Such comprehensive data sets have provided extensive information about the genomic localization of Bcl-6 and its corepressor complexes in various cellular settings. We next compared our results ( Fig. 3 and Supplementary Fig. 4c ) with published ChIP-seq data sets of the binding pattern of Bcl-6 in other lymphocyte subsets [30] [31] [32] [33] . We visualized the data from the published ChIP-seq studies with the UCSC Genome Browser and focused on the Bcl-6 peaks in proximity to the genes encoding molecules in the glycolysis pathway ( Fig. 4 and Supplementary Fig. 6 ). Notably, we identified Bcl-6 peaks in the regulatory regions of SLC2A3, SLC2A1 and PKM in B cells ( Fig. 4 and Supplementary Fig. 6 ). Additionally, Slc2a1 and Pkm were identified in the published list of genes with IL-2sensitive overlapping ChIP-seq peaks for Bcl-6 and the STAT family of transcription factors in T H 9 cells 33 . Together these data suggested that Bcl-6 associated with the loci of genes encoding molecules involved in the glycolysis pathway in both T cells and B cells in several different settings. Given the large number of genes functionally repressed by overexpressed Bcl-6 in primary T H 1 cells, we next assessed how widespread the association of Bcl-6 was with the loci of genes that were functionally repressed in the Bcl-6-overexpression experiments. The ChIP-seq data sets of B cells [30] [31] [32] revealed Bcl-6 peaks at most of the genes that were repressed by Bcl-6 expression in the primary T H 1 cell experiments, including HK2, TPI1, ALDOA, PFKL, PFKM, PCK2 and GRHPR ( Fig. 4 and Supplementary Fig. 6) . Many of the Bcl-6 peaks also contained overlapping peaks for the corepressor BCOR and, less often, peaks for the corepressor SMRT ( Fig. 4 and Supplementary Fig. 6 ), which suggested that Bcl-6 may act at least in part by 'preferentially' using a BTB domain-mediated BCOR repression mechanism to inhibit their expression 30 . Collectively, these data suggest that Bcl-6 probably has a direct role in the repression of an extensive network of the program of genes encoding molecules in the glycolytic pathway.
HIF-1a and c-Myc bind to glycolytic molecule-encoding loci
The inverse correlation between the IL-2-sensitive expression of HIF-1α and c-Myc versus that of Bcl-6, and the overlapping subset of genes identified by microarray analysis as being regulated by Bcl-6 and HIF-1α, suggested that the Bcl-6-dependent gene program might oppose the gene program directly regulated by HIF-1α and c-Myc. To assess this possibility, we first used ChIP to analyze primary T H 1 cells exposed to a high or low environmental concentration of IL-2 and examined the association of HIF-1α and c-Myc with a subset of the Bcl-6-repressed promoters. We found enrichment for the binding of c-Myc and HIF-1α at the Slc2a1, Plod2 and P4ha2 promoters in T H 1 cells maintained in a high environmental concentration of IL-2, which correlated with the expression of these genes (Fig. 5) . In contrast, the binding of c-Myc and HIF-1α with these promoters was reduced in a low environmental concentration of IL-2 ( Fig. 5) . We also found enrichment for binding of c-Myc at the Slc2a3 and Tpi1 promoters in T H 1 cells exposed to conditions of a high environmental concentration of IL-2 ( Fig. 5 and Supplementary Fig. 4d) .
We next extended the analysis of the genes encoding molecules in the glycolytic pathway by examining c-Myc ChIP-seq data sets from the ENCODE (Encyclopedia of DNA Elements) consortium 34 and a published HIF-1α ChIP-seq study 35 . There was substantial overlap of the c-Myc and Bcl-6 peaks at the loci for these genes, with many Bcl-6 peaks located at the same promoter regions as which the c-Myc peaks were located ( Fig. 4 and Supplementary Fig. 6) . Additionally, many genes identified in the overlapping subset of genes regulated by HIF-1α and Bcl-6 contained hypoxia-inducible HIF-1α peaks ( Fig. 4 and  Supplementary Fig. 6 ). For some genes, the HIF-1α peaks seemed to overlap the Bcl-6 peaks (for example, PKM, ALDOA and PFKFB3 in Fig. 4 and Supplementary Fig. 6) , whereas for others they were localized to different regions (for example, SLC2A1 and SLC7A5 in Figure 4 Genomic distribution of Bcl-6, HIF-1α and c-Myc throughout the loci of genes encoding molecules in the glycolysis pathway. ChIP-seq tracks of BCOR 30 , SMRT 30 and Bcl-6 (obtained with two independent antibodies: D8 and N3) 30 , HIF-1α (HIF1) in hypoxic conditions 35 , and c-Myc (from the ENCODE consortium 48 ), assessing the binding of those factors to PKM (top), HK2 (middle) and SLC2A1 (bottom) in OCI-Ly1 human B cell lymphoma cells or human umbilical vein endothelial cells (HUVECs) (left margin), all visualized with the UCSC Genome Browser; boxes indicate the BED file format, which provides the location of ChIP-seq peaks that span multiple consecutive nucloetides identified by peak-finder programs. The HIF-1α peak is from a Wiggle (WIG) file format (peak height, vertical axes). In gene diagrams (below browser images), gray arrows indicate direction of transcription. GEO accession codes for ChIP-seq data sets are in Online Methods 30, 31, 35 . Chr, chromosome; kb, kilobases; hg18, human genome version 18 (UCSC Genome Browser); CR621467, gene adjacent to SLC2A1. Fig. 4 and Supplementary Fig. 6 ). There was also a subset of genes that contained only Bcl-6 peaks without any detectable HIF-1α peaks (for example, B4GALT1 and PFKM in Supplementary Fig. 6) . Many of these genes had not been identified in the initial overlapping subset of genes regulated by HIF-1α and Bcl-6 but instead were repressed by Bcl-6 in our expanded analysis of the glycolysis pathway and also contained c-Myc peaks (Supplementary Fig. 6 ). In conjunction with published studies 15, 17 , these data suggested a role for c-Myc and HIF-1α in directly activating a subset of genes encoding molecules important in the glycolysis pathway and associated pathways, and a repressive role for Bcl-6 in direct opposition to that gene program.
T-bet is required for enhanced glycolysis in T H 1 cells
Bcl-6 has emerged as one of the critical factors that functionally regulates memory potential, and the activity of Bcl-6 must be precisely controlled to initiate either the memory cell gene program or the T FH cell gene program 5, 7, 8, 22 . In T H 1 cells, formation of the T-bet-Bcl-6 complex masks the Bcl-6 DNA-binding domain because the DNA-binding zinc fingers are also required for the interaction with T-bet 9, 29 . Thus, T-bet can hold Bcl-6 activity in check in effector T H 1 cells because a high ratio of T-bet to Bcl-6 promotes complex formation, which dampens the potential of Bcl-6 to regulate its own target gene program. The relative balance of T-bet and Bcl-6 varies substantially in effector T cells versus memory T cells, and high T-bet expression is important for the development of short-lived effector cells 4, [36] [37] [38] . Collectively, these observations led us to hypothesize that the relative balance of T-bet and Bcl-6 might have a role in defining the state of the glycolysis-pathway gene program.
To address that possibility, we first examined the expression pattern of genes encoding molecules in the glycolytic pathway in wild-type versus T-bet-deficient primary T H 1 cells. If T-bet inhibits Bcl-6 from repressing genes encoding molecules involved in glycolysis in effector T H 1 cells, then the expression of target genes encoding glycolytic molecules would be inhibited in T-bet-deficient cells because Bcl-6 is no longer held in check by T-bet in this setting 9 . Consistent with that prediction, the expression of many such genes was lower in T-bet-deficient cells than in wild-type effector T H 1 cells ( Fig. 6a and Supplementary Fig. 7) . These included genes encoding rate-limiting enzymes, such as Aldoc and Pkm, as well as Slc2a3 and Slc2a1, which encode glucose transporters ( Fig. 6a and Supplementary Fig. 7) . Consistent with the reduced expression of these genes, there was also less of the permissive modification of histone H3 acetylated at Lys9 present at the promoters of Aldoc, Pkm, Slc2a3 and Slc2a1 in T-bet-deficient cells than in primary wildtype effector T H 1 cells (Fig. 6b) . We observed similar trends for the expression and histone-modification patterns of additional target genes identified in the microarray comparison of Bcl-6 and HIF-1α ( Supplementary Fig. 7) .
We next monitored lactate production in the setting of wild-type and T-bet-deficient CD4 + T cells to determine whether the observed gene-expression changes had functional consequences on glycolysis activity. Similar to published findings obtained for CD8 + T cells 17 , lactate production was induced more in wild-type T H 1 cells in the presence of a high environmental concentration of IL-2 than in the presence of a low concentration of IL-2 ( Fig. 6c) . Lactate production was significantly lower in T-bet-deficient cells cultured with a high environmental concentration of IL-2 than in their wild-type T H 1 counterparts cultured with the same concentration of IL-2 ( Fig. 6c) . Notably, the concentration of lactate in T-bet-deficient cells exposed to a high environmental concentration of IL-2 was similar to that in wild-type cells exposed to a low concentration of IL-2 (Fig. 6c) . These data suggested that in T H 1 cells, T-bet expression was required for Figure 5 The association of c-Myc and HIF-1α inversely correlates with binding of Bcl-6 at the promoters of genes encoding molecules involved in glycolysis. (a,b) ChIP-PCR analysis of T H 1-polarized cells maintained in the presence of a high or low concentration of IL-2, assessed by immunoprecipitation of chromatin with anti-c-Myc (a) or anti-HIF-1α (b) or a nonspecific IgG control antibody (a,b) followed by quantitative PCR analysis of various promoter regions (vertical axes) with promoterspecific primers (results normalized and presented as in Fig. 3c ). NS, not significant (P = 0.0577 (Tpi1 in a) and P = 0.0981 (Plod2 in b)); *P < 0.05 (unpaired Student's t-test). Data are representative of three independent experiments (error bars, s.e.m.). A r t i c l e s the IL-2-dependent increase in glycolysis activity. Consistent with the observation that the robust induction of Bcl-6 expression in conditions of a low environmental concentration of IL-2 is sufficient to bypass T-bet-mediated control 9 , lactate production in wild-type and T-bet-deficient cells exposed to a low environmental concentration of IL-2 was similar ( Fig. 6c) . Together these data supported the hypothesis that T-bet was needed to inhibit the modest amounts of Bcl-6 expressed in effector T H 1 cells to prevent Bcl-6 from dominantly repressing the expression of genes encoding molecules in the glycolysis pathway and that this activity was functionally important for promoting glycolysis in effector T H 1 cells. In contrast, conditions of a low environmental concentration of IL-2 substantially enhanced Bcl-6 expression, which overcame T-bet-mediated control in T H 1 cells, allowing Bcl-6 to downregulate glycolysis and create a metabolic state more compatible with the formation of memory cells.
T-bet restrains Bcl-6 at glycolysis molecule-encoding genes
We next wanted to more directly address whether the role of T-bet in promoting the expression of genes encoding molecules in the glycolysis pathway might be mediated through its ability to functionally regulate Bcl-6 activity. To address this question, we needed to separate the mechanistic activity that T-bet uses to modulate Bcl-6 activity from all other aspects of the transcription-regulatory potential of T-bet. To accomplish this goal, we created a construct that contains only the carboxy-terminal domain (amino acids 300-530) of T-bet (T-bet(300-530)), which is the domain shown to be required for the physical interaction of T-bet with Bcl-6 (ref. 9). Notably, this truncated protein lacked the centrally located T-box DNA-binding domain as well as an amino-terminal domain needed for the transactivation potential of T-bet. We first used coimmunoprecipitation analysis to demonstrate that the carboxy-terminal domain of T-bet alone was sufficient to mediate the interaction with Bcl-6 ( Fig. 7a) . We next assessed whether expression of T-bet(300-530) was sufficient to inhibit Bcl-6 from repressing its direct DNA-binding elements. To address this, we first did a series of experiments with a promoter-reporter construct that contains three Bcl-6 DNA-binding elements upstream of a minimal promoter (3×-Bcl-6) 9 . Repression of the 3×-Bcl-6 promoter-reporter construct is completely dependent on the Bcl-6 DNA-binding sites 9 . We transfected the 3×-Bcl-6 promoter-reporter construct into the A20 mouse B cell lymphoma line, together with either a control vector or one expressing T-bet(300-530). Notably, there was enhancement in 3×-Bcl-6 promoter-reporter activity in the presence of T-bet(300-530) (Fig. 7b) . In contrast, the expression of another domain of T-bet (amino acids 120-331) that does not interact with Bcl-6 (T-bet(120-331)) had no effect on the activity of the 3×-Bcl-6 promoter-reporter construct (Fig. 7b) . In additional control experiments addressing specificity, T-bet(300-530) had no activity when Bcl-6 expression was diminished by stimulation (Supplementary Fig. 8b,c) . Together these data supported the interpretation that the physical interaction between T-bet and Bcl-6 inhibited Bcl-6 from repressing its own DNA-binding sites and that this experimental system recapitulated the principles of the T-bet-dependent control of Bcl-6 without introducing the DNAbinding-dependent transcriptional activity of T-bet into the cell.
To test the hypothesis that T-bet has the ability to functionally control the activity of Bcl-6 at genes encoding molecules important in glycolysis, we transfected promoter-reporter constructs for several such genes, together with empty vector or a vector expressing T-bet(300-530) or, as a control, T-bet(120-331). The expression of T-bet(300-530) enhanced the promoter-reporter activity of target genes encoding glycolytic molecules, including Slc2a3, Slc2a1, Pkm, Aldoc and Tpi1, but expression of the control T-bet(120-331) did not ( Fig. 7c and Supplementary Fig. 8d) . T-bet(300-530) also enhanced the promoter activity of Plod2 and P4ha2 (Fig. 7c and Supplementary  Fig. 8d) . In control experiments, overexpression of Bcl-6 in conjunction with T-bet(300-530) restored the Bcl-6-dependent repression npg of the promoter-reporter constructs (Fig. 7d) . Thus, the interaction between T-bet and Bcl-6 functionally inhibited the Bcl-6-dependent repression of the promoter activity of target genes encoding molecules of the glycolysis pathway. Finally, we used this experimental system to assess whether the molecular balance of T-bet and Bcl-6 might influence the endogenous expression of genes encoding molecules important in glycolysis. Similar to the results obtained with the promoter-reporter constructs, expression of T-bet(300-530) was sufficient to modestly enhance the endogenous expression of a subset of these genes ( Fig. 7e  and Supplementary Figs. 8e and 9) . For these experiments, we used human Ramos B lymphoblastoid cells and mouse A20 B cells, which have constitutive expression of Bcl-6; this provided support for the possibility that this mechanism might be conserved in different settings. Collectively, these data indicated that the interaction between T-bet and Bcl-6 functionally controlled the ability of Bcl-6 to repress a subset of target genes encoding molecules important for glycolysis, which linked the molecular balance of T-bet and Bcl-6 to the regulation of the glycolysis-pathway gene program.
DISCUSSION
Here we identified a role for Bcl-6 in repressing genes encoding molecules important in the glycolysis pathway and associated pathways. IL-2 signaling regulates several key transcription factors required for the activation and differentiation of T cells 39, 40 . IL-2 signaling promotes the activity of c-Myc and HIF-1α, whereas it inhibits Bcl-6 expression, which creates reciprocal expression patterns for these factors in effector cell populations versus memory cell populations 9, 17, 27 . The close correlation between the expression of Bcl-6 and the repression of genes encoding molecules in the glycolysis pathway in the presence of a low environmental concentration of IL-2 led us to hypothesize that Bcl-6 might be one of the critical regulatory proteins that inhibits glycolysis in T cells. Indeed, Bcl-6 associated with the loci of many genes encoding molecules in the glycolysis pathway, including rate-limiting enzymes such as those encoded by Pkm and Hk2, and this correlated with their repression in T H 1 cells in an IL-2-sensitive manner. These results, in conjunction with the GEO2R microarray analysis of Bcl6 −/− cells, the Bcl-6-overexpression studies of primary T H 1 cells and the promoter-reporter experiments, indicated that Bcl-6 was an IL-2-sensitive factor that directly repressed genes encoding molecules in the glycolysis pathway. Finally, T-bet was required for the IL-2-dependent induction of glycolysis in effector T H 1 cells, as T-bet inhibited the ability of Bcl-6 to dominantly repress target genes encoding glycolytic molecules. Therefore, T-bet indirectly served to promote the expression of genes encoding molecules in the glycolysis pathway in effector T H 1 cells by inhibiting Bcl-6 activity.
Identifying the types of genes that Bcl-6 regulates to serve its role in lineage-commitment 'decisions' has been somewhat enigmatic because Bcl-6 is a transcription repressor, and it has been difficult to envision the pathways that are directly regulated by Bcl-6 to promote a specific cellular state. In commitment to the T FH cell and B cell fate, at least one of its direct target genes is Prdm1 (which encodes the transcription repressor Blimp-1) 2, 9, 41, 42 . However, the reciprocal regulation of Bcl-6 and Blimp-1 does not explain many of the altered cellular characteristics related to Bcl-6 expression. The finding of a role for Bcl-6 in regulating glycolysis in T cells has revealed a previously unknown cellular process that Bcl-6 controls that is probably important for defining effector states versus memory states in T cells. In this context, the metabolic state of cells of the immune system has a profound effect on their functional ability 12, 13, 21, 43 , and experimentally manipulating the ability of the cell to use the glycolysis pathway for energy production can alter the effector fate-versus-memory fate 'decision' 14, 21 . Specifically, inhibiting glycolysis promotes the formation of memory cells 21 . Therefore, if the glycolysis program in effector cells can be turned off in response to changing environmental cues during the course of an immune response, such as conditions of waning IL-2 concentrations, this may initiate the transition of an effector cell into a memory cell. Our study has demonstrated that Bcl-6 dominantly repressed the glycolytic gene program, even in the presence of HIF-1α and c-Myc. This suggests a hierarchy in the competing regulatory pathways involved in the differentiation 'decisions' associated with effector and memory potential. This leads to the speculation that if Bcl-6 expression is induced in the effector cell population during the course of an immune response, the dominant nature of the Bcl-6-dependent repression of the glycolysis pathway might alter the metabolic state of the cell to promote memory formation.
Another notable aspect of the identification of a role for Bcl-6 in the IL-2-sensitive repression of genes encoding molecules in the glycolysis pathway is that Bcl-6 is also the lineage-specifying factor for T FH differentiation. It has been proposed that the gene-expression programs of CD8 + memory T cells and CD4 + T FH cells are related 22 .
The data now available in the field suggest that a gradient of Bcl-6 expression serves to define whether a memory program or a T FH program will be initiated. That is consistent with the findings that a similar composition of signaling pathways and regulatory factors contribute to the differentiation potential of both cell populations but that there may be different thresholds for these events that are necessary for generating each unique cell population 4, 6, 44, 45 . It will be informative to determine in future experiments whether the abundance of Bcl-6 promotes the expression of unique subsets of target genes that are more predominant in the memory phenotype or T FH phenotype or if instead target specificity is related to cofactor availability. In this context, it will be important to determine how the Bcl-6-dependent regulation of the glycolytic-pathway gene program fits into the potential for each of these cellular states.
We speculate that the findings of our study might also relate to the oncogenic potential of Bcl-6. Highly proliferating cancer cells are prone to express a glycolytic gene program, which is similar to the expression profile of the proliferating effector cells of the immune response 12, 46 . The oncogenic potential of Bcl-6 at first glance appears to be incompatible with both its known role in the development of memory T cell and its newly identified role in the inhibition of the glycolysis-pathway gene program. However, studies examining the survival requirements of leukemia cancer stem cells have found that Bcl-6 expression in these cells, which constitute a relatively quiescent population, is important for their survival, and loss of Bcl-6 expression increases the proliferative capacity of the stem cells 47 . Such data suggest that the oncogenic potential of Bcl-6 in cancer stem cells may be similar to its role in long-lived memory cell populations. In the context of these more quiescent cell populations, inhibiting the glycolysis-pathway gene program may be an advantageous activity that Bcl-6 uses to promote long-term survival.
Finally, we note that creating a gradient of Bcl-6 activity in T H 1 cells can also be achieved by modulating the relative molecular balance of T-bet and Bcl-6. This molecular balance is sensitive to environmental signals such as IL-2; this allows flexibility in aspects of the T H 1 cell and T FH cell-like gene-expression patterns 9 . Here we have extended those findings to demonstrate that the IL-2-dependent induction of glycolysis required T-bet, most probably because the relative molecular balance of T-bet and Bcl-6 modulated the ability of Bcl-6 to dominantly repress genes encoding molecules involved in glycolysis. This creates a scenario in which the high expression of npg T-bet in effector T H 1 cells serves multiple purposes, which include promoting the expression of genes specific to the T H 1 lineage as well as ensuring that genes encoding molecules in the glycolysis pathway have abundant expression. We note that there is a gradient of T-bet expression in effector and memory T cell populations 4, [36] [37] [38] . Thus far it has been unclear what aspects of the gene-expression program might be affected by the differences in T-bet expression. The data presented here lead to the hypothesis that the ratio of T-bet to Bcl-6 in T cells influences the expression of the glycolytic gene program. This also suggests an essential connection between the lineagespecifying transcription factors that have long been known to define the functional potential of T cells and the regulation of the metabolic state of the cell. Much research is still needed to address these topics, including detailed metabolomic profiling of these cell populations, but our study has provided evidence of the involvement of lineagespecifying transcription factors in modulating the expression of the metabolic gene program.
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